Continuous-Infusion Adriamycin

[1]  G. Hortobagyi,et al.  Doxorubicin‐induced congestive heart failure in adults , 1985, Cancer.

[2]  S. Wallace,et al.  Increased therapeutic index of weekly doxorubicin in the therapy of non-small cell lung cancer: a prospective, randomized study. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  S. Wallace,et al.  A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  F. Torti,et al.  Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsy. , 1983, Annals of internal medicine.

[5]  R. Benjamin,et al.  Adriamycin therapy by continuous intravenous infusion in patients with metastatic breast cancer , 1982, Cancer.

[6]  S. Wallace,et al.  Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. , 1982, Annals of internal medicine.

[7]  D. V. Von Hoff,et al.  Risk factors for doxorubicin-induced congestive heart failure. , 1979, Annals of internal medicine.

[8]  L. Goldman,et al.  Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. , 1979, The New England journal of medicine.

[9]  J. Mason,et al.  Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. , 1978, Annals of internal medicine.

[10]  A. Weiss,et al.  Experience with the use of adriamycin in combination with other anticancer agents using a weekly schedule, with particular reference to lack of cardiac toxicity , 1977, Cancer.

[11]  R. Benjamin,et al.  Adriamycin cardiomyopathy—risk factors , 1977, Cancer.

[12]  J. Mason,et al.  Adriamycin cardiotoxicity: Endomyocardial biopsy evidence of enhancement by irradiation , 1977, The American journal of surgical pathology.

[13]  S K Carter,et al.  Adriamycin. A new anticancer drug with significant clinical activity. , 1974, Annals of internal medicine.

[14]  J. Pitha,et al.  A clinicopathologic analysis of adriamycin cardiotoxicity , 1973, Cancer.

[15]  R. Benjamin,et al.  Infusion Chemotherapy for Soft Tissue Sarcomas , 1983 .

[16]  T. Pajak,et al.  Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity. , 1980, Cancer treatment reports.

[17]  R. Benjamin.  A practical approach to adriamycin (NSC 123127) toxicology , 1975 .